Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 11 Thoracic 5 Sarcoma 3 Lymphoid 3 Tumor-Agnostic 1 Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 74 pembrolizumab 59 Carboplatin 55 Bevacizumab 54 Specimen Handling 47 Magnetic Resonance Spectroscopy 38 Cisplatin 32 olaparib 28 Gemcitabine 25 liposomal doxorubicin 24 Biopsy 20 Taxes 18 Topotecan 17 Nivolumab 17 Doxorubicin 15 Cyclophosphamide 15 Immunoglobulin G 14 Disulfides 14 niraparib 12 fludarabine 12 lenvatinib 11 Surveys and Questionnaires 11 Letrozole 11 atezolizumab 10 Drug Therapy 10 durvalumab 9 Fulvestrant 9 Docetaxel 9 Brachytherapy 9 mirvetuximab soravtansine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Vinorelbine × Gynecologic × 90 days × Clear all

NCT06459180 2026-05-27

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡